| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/29/2004 | WO2004063195A1 Pyridopyrimidine kinase inhibitors |
| 07/29/2004 | WO2004063190A1 Fused heterocyclic derivates as ppar modulators |
| 07/29/2004 | WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004063159A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 07/29/2004 | WO2004063156A1 Novel indole derivates as fabp-4 inhibitors |
| 07/29/2004 | WO2004063155A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | WO2004063151A2 Novel tyrosine kinase inhibitors |
| 07/29/2004 | WO2004062665A1 Heteroaryl- substituted pyrrolo` 2, 3- b! pyridine derivatives as crf receptor antagonists |
| 07/29/2004 | WO2004050629A3 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 07/29/2004 | WO2004041777A3 Heteroarylpiperidine modulators of chemokine receptor activity |
| 07/29/2004 | WO2004037213A3 Nuclear hormone receptor compounds, products and methods employing same |
| 07/29/2004 | WO2004035577A3 Pre-organized tricyclic integrase inhibitor compounds |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004018419B1 Benzimidazole quinolinones and uses thereof |
| 07/29/2004 | WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | US20040147760 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 07/29/2004 | US20040147747 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147588 Phosphodiesterase inhibitor; tumor necrosis factor antagonist; autoimmune diseases; sepsis; malaria ; skin disorders; anticancer agents; antiarthritic agents; Crohn's disease; inflammatory bowel disorders |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147568 Obesity; dietetics; adjust density of bones, muscles |
| 07/29/2004 | US20040147561 Pyrid-2-one derivatives and methods of use |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147549 Antiviral compounds |
| 07/29/2004 | US20040147548 2-NH-heteroarylimidazoles with antibacterial activity |
| 07/29/2004 | US20040147547 HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 07/29/2004 | US20040147546 Heterocyclic compounds |
| 07/29/2004 | US20040147545 Therapy for infection |
| 07/29/2004 | US20040147544 Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/29/2004 | US20040147543 Immonomoderators; viricides; anticancer agents |
| 07/29/2004 | US20040147542 Chemical compounds |
| 07/29/2004 | US20040147538 Fused heterocyclic compounds |
| 07/29/2004 | US20040147533 Sulfonamido substituted imidazopyridines |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040146745 blue light; excellent in color purity; high luminance and efficiency is possible by driving at low voltage; excellent in stability in repeated use; 2-substituted benzimidazole compound |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | CA2510516A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | CA2509202A1 Fused heterocyclic derivatives as ppar modulators |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440071A1 Imidazopyridine compounds as 5-ht 4? receptor modulators |
| 07/28/2004 | EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1176958B1 Novel catechols as antimicrobial agents |
| 07/28/2004 | EP1140862A4 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | CN1516589A N-biphenylcarbonyl-anjd N-phenylpyridylcarbonyl substituted bi-and tricyclic azepines and diazepines as vasopressing agonists |
| 07/28/2004 | CN1516584A Spiropyrazole compounds |
| 07/28/2004 | CN1516582A 抗病毒化合物 Antiviral compounds |
| 07/28/2004 | CN1515570A Preparation method of pyrazolo [4,3-C] pyridine-3-ketone L-tartate |
| 07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
| 07/28/2004 | CN1159297C N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide |
| 07/27/2004 | US6768007 Substituted 3′,4′-di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/22/2004 | WO2004060893A1 Pyrrolopyridine potassium channel openers |
| 07/22/2004 | WO2004060892A1 Fused n-containing heterocyclic compounds and medicinal use thereof |
| 07/22/2004 | WO2004060891A1 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 07/22/2004 | WO2004060890A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004034983A3 Preparation of triazospiro compounds |
| 07/22/2004 | WO2004020438A3 Novel processes and intermediates for preparing triazolo-pyridines |
| 07/22/2004 | WO2004005289B1 Efficient synthesis of pyropheophorbide a and its derivatives |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | US20040143119 five different crystal forms having different physical properties such as different melting point, single crystal x-ray, powder x-ray, and solid state NMR; potent inhibitor of MAP kinases |
| 07/22/2004 | US20040143116 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040142997 Alzheimer's disease |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/22/2004 | US20040142975 Antiarthritic agents; canticancer agents; antitumor agents; cardiovascular diosrders; skin diosrders; vision defects; antiinflammatory agents |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142956 Piperidine derivatives |
| 07/22/2004 | US20040142955 Psychological disorders; anxiolytic agents; antidepressants; bipolar disorders; analgesics; asthma ; hypotensive agents; obesity; antiepileptic agents; eating disorders; antidiabetic agents; irritable bowel disorders; Alzheimer's disease; cognition |
| 07/22/2004 | US20040142949 Compounds, compositions, and methods |
| 07/22/2004 | US20040142945 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 07/22/2004 | US20040142942 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/22/2004 | US20040142941 Therapeutic compounds |
| 07/22/2004 | US20040142936 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 07/22/2004 | US20040142930 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects |
| 07/22/2004 | US20040142928 particularly against herpes viruses |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process. |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | CA2509213A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1438962A1 DRUGS COMPRISING COMBINATION OF TRIAZASPIRO 5,5 U NDECANE DERIVATIVE WITH CYTOCHROME P450 ISOZYME 3A4 INHIBITOR AND/OR P−GLYCOPROTEIN INHIBITOR |
| 07/21/2004 | EP1438958A1 Carbamate substituted imidazoquinolines |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438308A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists |